Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.81 +0.24 (4.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $45.34 | |||
| Open | $5.57 | 52 Week Low | $15.92 | |||
| Day High | $5.93 | P/E | 2.49 | |||
| Day Low | $5.39 | EPS | $2.33 | |||
| Volume | 3,072,864 | |||||
